Atlas of the evolution of psoriasis lesions under Remicade : A dynamic standardized photographic library of moderate to severe psoriasis subjects treated with infliximab

Trial Profile

Atlas of the evolution of psoriasis lesions under Remicade : A dynamic standardized photographic library of moderate to severe psoriasis subjects treated with infliximab

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2014

At a glance

  • Drugs Infliximab (Primary)
  • Indications Psoriasis
  • Focus Therapeutic Use
  • Acronyms PHODYPSO
  • Sponsors Merck Sharp & Dohme; Schering-Plough
  • Most Recent Events

    • 06 Sep 2013 Trial association changed from Schering-Plough to Merck & Co as reported by ClinicalTrials.gov.
    • 28 Jan 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
    • 28 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top